Baird Medical Investment Holdings Ltd

corporate_fare Company Profile

Baird Medical Investment Holdings Ltd

BDMD·NASDAQ·Life Sciences·CIK 0001982444

We are a specialized healthcare innovator focused exclusively on thyroid-related diseases. We develop non-invasive solutions for thyroid treatment, aiming to cover the entire process from early screening and diagnosis to robotic-assisted ablation and post-treatment care. Our key products include a thyroid microwave ablation system, which we have successfully developed and commercialized. Our research and development pipeline features AI-integrated robotic systems. Our strategy combines hardware innovation, software intelligence, and a comprehensive system approach. We ranked first among microwave ablation medical device providers in the treatment of thyroid nodules and breast lumps in the PRC in terms of sales revenue and sales volume of microwave ablation needles in 2022, according to the Frost & Sullivan Report. Additionally, we were the third largest microwave ablation medical device provider in the PRC in terms of sales revenue in 2022. Microwave ablation is a minimally invasive treatment that uses heat from microwave energy to denaturalize and coagulate tumor cell protein. This treatment is applied to benign and malignant tumors.

Baird Medical Investment Holdings Ltd (NASDAQ:BDMD) is a publicly traded company in the Life Sciences sector. Wiseek monitors BDMD SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

Baird Medical Establishes NYC Global HQ for U.S. Commercial Push (2026-06-09)
Baird Medical Files $50M Universal Shelf Registration Amidst Financial Weakness (2026-05-22)
Baird Medical Reports Significant 2025 Net Loss and Revenue Decline Amid Soaring Expenses and Liquidity Concerns (2026-04-24)
Baird Medical Dismisses Auditor, Discloses Material Weaknesses in Financial Controls (2026-02-10)
Baird Medical registers 34.4M shares for resale by existing holders, creating significant market overhang (2026-01-16)

Financial Snapshot

Fiscal year ended December 31, 2025

Revenue

$22.54M

Net Income

-$27.28M

Diluted EPS

-$0.98

Op. Cash Flow

-$1.34M

Free Cash Flow

-$1.39M

Gross Profit

$18.88M

Operating Income

-$25.63M

Cash & Equivalents

$178.32K

Total Debt

$8.72M

Debt / Equity

0.28×

Net Margin

-121.0%

Shares Outstanding

30.75M sh

Source: 20-F · filed 2026-04-24 · accession 0001104659-26-048641

Insider Transactions

BDMD files as a Foreign Private Issuer (FPI). Under SEC Exchange Act Section 16(a), officers, directors, and 10% owners of FPIs are exempt from Form 4 insider-transaction reporting requirements. Comparable disclosures, when applicable, appear in the company's Form 20-F (annual) or Form 6-K (interim) filings on SEC EDGAR.

Browse all tickers starting with B →

show_chartPrice Chart

Loading chart...

feed BDMD - Latest Insights

Filing Type

Date Range

BDMD

Jun 09, 2026, 8:30 AM EDT

Source: PR Newswire

Importance Score:

Baird Medical Establishes NYC Global HQ for U.S. Commercial Push

Price at Filing: $1.26

Real-time Price: $1.25

Change: -$0.0136 (-1%)

Market Cap: $51.224M

Sentiment: Positive

View Wiseek Article

BDMD

May 22, 2026, 9:01 AM EDT

Filing Type: F-3

Importance Score:

Baird Medical Files $50M Universal Shelf Registration Amidst Financial Weakness

Price at Filing: $1.64

Real-time Price: $1.25

Change: -$0.390 (-24%)

Market Cap: $51.224M

Sentiment: Negative

View Wiseek Article

BDMD

Apr 24, 2026, 4:35 PM EDT

Filing Type: 20-F

Importance Score:

Baird Medical Reports Significant 2025 Net Loss and Revenue Decline Amid Soaring Expenses and Liquidity Concerns

Price at Filing: $1.87

Real-time Price: $1.25

Change: -$0.6195 (-33%)

Market Cap: $51.224M

Sentiment: Negative

View Wiseek Article

BDMD

Feb 10, 2026, 7:59 AM EST

Filing Type: 6-K

Importance Score:

Baird Medical Dismisses Auditor, Discloses Material Weaknesses in Financial Controls

Price at Filing: $0.947

Real-time Price: $1.25

Change: +$0.303 (+32%)

Market Cap: $51.224M

Sentiment: Negative

View Wiseek Article

BDMD

Jan 16, 2026, 4:32 PM EST

Filing Type: 424B3

Importance Score:

Baird Medical registers 34.4M shares for resale by existing holders, creating significant market overhang

Price at Filing: $1.24

Real-time Price: $1.25

Change: +$0.010 (+0.81%)

Market Cap: $51.224M

Sentiment: Negative

View Wiseek Article

corporate_fare Company Profile